Skip to main content
Clinical Trials/NCT07343856
NCT07343856Enrolling By InvitationNot Applicable

Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID

Oncology Center,Ministry Of Heath,Uzbekistan1 site in 1 country50 target enrollmentStarted: December 5, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Number of Participants With Bioelectrical Response Patterns Consistent With Viral Persistence

Study Overview

Brief Summary

This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.

The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.

The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.

Detailed Description

This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.

The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.

The study involves a single-session, non-invasive diagnostic procedure without pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years or older
  • History of confirmed SARS-CoV-2 infection
  • Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection
  • Ability to provide informed consent
  • Willingness to undergo non-invasive bioelectrical diagnostic assessment

Exclusion Criteria

  • Acute infectious disease at the time of enrollment
  • Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment
  • Implanted electronic medical devices (e.g., pacemaker)
  • Pregnancy or breastfeeding
  • Inability to comply with study procedures

Outcomes

Primary Outcomes

Number of Participants With Bioelectrical Response Patterns Consistent With Viral Persistence

Time Frame: At enrollment (single diagnostic session)

Non-invasive diagnostic assessment using electroacupuncture-based medicament testing to identify bioelectrical response patterns consistent with viral antigen persistence in participants with post-viral conditions.

Secondary Outcomes

  • Distribution of Bioelectrical Reactivity Patterns During Medicament Testing(Baseline(Day 1))

Investigators

Sponsor
Oncology Center,Ministry Of Heath,Uzbekistan
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials